Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

NPO Nauka reported for 2023 by RAS

3/29/24 NAUK

SFI reported for 2023 according by RAS

3/29/24 SFIN

Severstal increased productivity of mill 2000 at CherMK

3/29/24 CHMF

Lukoil expects to restore the Nizhny Novgorod refinery in 1-2 months

3/29/24 LKOH

Svetofor reported for 2023 by RAS

3/29/24 SVET

Korshunovsky GOK reported for 2023 by RAS

3/29/24 KOGK

One third of Nornickel's sales come from the US and Europe

3/29/24 GMKN

Etalon opens sales in a flagship project in St. Petersburg

3/29/24 ETLN

Acron increased its stake in Verkhnekamsk Potash Company

3/29/24 AKRN

Alrosa issued digital financial assets diamonds

3/29/24 ALRS